Active, Not Recruiting
A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)
NCT05252585
- Conditions
- Angiomyolipoma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
- Locations
-
- Novartis Investigative Site Taichung, Taiwan ROC, Taiwan
- Novartis Investigative Site Taoyuan, Taiwan ROC, Taiwan
- Novartis Investigative Site Taipei, Taiwan
- Novartis Investigative Site Taoyuan, Taiwan